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Henry Ford Hosp. Med. Bull.
Vol. 11, September, 1963

COMMENT ON EMETINE IN THE TREATMENT OF AMEBIASIS

Editor's Note: It is gratifying, and sometimes surprising, how far travel the ripples when
a small stone is cast into a quiet pond. A welcome and informative letter was received from
a correspondent in India in response to the case of "Fever, Chills, Hepatomegaly, and
Debility" (Henry Ford Hosp. Med. Bull. 1 1:65, 1963). Because of its origin and pertinent
comment, an abridged version of the letter is reproduced below.

Dear Doctor Haubrich:
We feel highly honored in this little 100 bed hospital in the interior of India
to receive the Henry Ford Hospital Medical Bulletin. It was thus that I came across
your comment on emetine in amebiasis in the discussion of hepatomegaly in the issue
for March 1963, page 69.

The more one works with parasites of this type the more one realizes that
there is great variety in the strains of similar parasites throughout the world. We
feel this is also true of bacteria. The most graphic demonstration of the difference
lies in the drug-sensitivity of the tuberculosis organism usually found in India today.
There is no doubt that the same applies to larger pathogens as well. For instance,
we find that Piperazine Hydrate and its allied drugs have a very slight effect on the
ascarides of this part of India, in spite of favorable reports from other parts of the
world.

In

amebiasis we find that the protozoans in this part of India are very

responsive to emetine and are extremely resistant to most other forms of current
treatment. Hence, our experience makes us disagree with your statement, "Emetine
has been almost abandoned". At our hospital, we detect about 300 cases of vegetative
ameba per year, and, including out-patients, about double that number of cyst cases.
In the past 9 years, we have treated approximately 2,500 cases of vegetative amebiasis
in this hospital.

By careful follow-up we have found that the most certain method, by far, in
handling vegetative E. histolytica is to bring the person into the hospital for 10 days
and have intramuscular emetine 60 mgs. with Strychnine 1.0 mgs. given each night.
A blood pressure reading is taken daily, and treatment is discontinued if the blood
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pressure falls below 100 systolic. The heart is checked daily for extrasystoles. This
is then followed by 10 days out-of-hospital treatment with Choroquin and Diodoquin
by mouth. We have had many re-checks of these cases and find nothing to equal
the above, even though we too were persuaded that emetine was old fashioned.
For E. histolytica cysts we find that a 5 day course of one tablet 3 times daily
of Camoform (Parke-Davis) is the best. We are now trying out parallel cases with
Mexaform (Ciba) but do not find it quite so satisfactory as it requires 6 tablets
daily for 10 days hence, the longer treatment has less chance of being completed
by a simple village patient. We have tried Chloroquin alone and Chloroquin with
Diodoquin also these with bismuth and arsenical preparations which are much advertised out here. We found that they just did not bring about negative stools.
There is so much amebiasis in India that every drug company is trying hard
to get the market for their preparation.

Some doctors are notorious for accepting

financial "assistance" from drug firms to "do research" which is far from reliable.
In this atmosphere unbiased observation is hard to carry out. We do our best.
Yours fraternally,
ROBERT B . M C C L U R E ,

M.D., F.R.C.S.

Ratlam Mission Hospital
United Church of Canada Mission
Ratlam, Madhya Pradesh, India.
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